Author:
Petry Karl Ulrich,Luyten Alexander,Justus Annika,Iftner Angelika,Strehlke Sarah,Reinecke-Lüthge Axel,Grunwald Elisabeth,Schulze-Rath Renate,Iftner Thomas
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Schiffman M, Clifford G, Buonaguro FM: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009, 4: 8-10.1186/1750-9378-4-8.
2. Bosch FX, de Sanjosé S: Human papillomavirus and cervical cancer – burden and assessment of causality. J Natl Cancer Inst Monogr. 2003, 31: 3-13.
3. Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R, Gissmann L, Grundhewer H, Ikenberg H, Kaufmann AM, Klusmann J, Kopp I, Pfister H, Rzany B, Schneede P, Schneider A, Smola S, Winter-Koch N, Wutzler P, Gross G: Short version of the German evidence-based guidelines for prophylactic vaccination against HPV-associated neoplasia. Vaccine. 2009, 27: 4551-4559. 10.1016/j.vaccine.2009.03.086.
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC): Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2007, 56 (RR-2): 1-24.
5. European Centre for Disease Prevention and Control: Introduction of HPV vaccines in EU countries – an update. 2012, Stockholm: ECDC
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献